In immunocatalysis, antibodies are designed to have catalytic activity. This is achieved by engineering the active site of the antibody to mimic the transition state of a chemical reaction. The antibody binds to the substrate and stabilizes the transition state, thereby lowering the activation energy and speeding up the reaction. The process involves the use of techniques such as directed evolution and rational design to develop antibodies with desired catalytic properties.
